120 related articles for article (PubMed ID: 10888201)
1. Synthesis and anti-aggregatory activity of linear retro-inverso RGD peptides.
Dal Pozzo A; Fagnoni M; Bergonzi R; Vanini L; de Castiglione R; Aglio C; Colli S
J Pept Res; 2000 Jun; 55(6):447-54. PubMed ID: 10888201
[TBL] [Abstract][Full Text] [Related]
2. Design and Synthesis of Non-peptide RGD Mimics for Evaluation of Their Utility as Anti-platelet Agents.
Higuchi K; Hikita H; Murayama A; Yuri D; Kobayakawa N; Takahashi T; Kojima S; Ueno H; Hatakeyama T; Kato A; Tayu M; Oyama E; Sugiyama S; Ishii K; Takahashi H; Kawasaki T
Chem Pharm Bull (Tokyo); 2016; 64(12):1726-1738. PubMed ID: 27904082
[TBL] [Abstract][Full Text] [Related]
3. [The structure-antiaggregative activity relationship in a series of Arg-Gly-Asp analogs].
Mel'nik OV; Martinovich VP; Golubovich VP
Bioorg Khim; 2006; 32(2):137-43. PubMed ID: 16637284
[TBL] [Abstract][Full Text] [Related]
4. A three-residue cyclic scaffold of non-RGD containing peptide analogues as platelet aggregation inhibitors: design, synthesis, and structure--function relationships.
Stavrakoudis A; Bizos G; Eleftheriadis D; Kouki A; Panou-Pomonis E; Sakarellos-Daitsiotis M; Sakarellos C; Tsoukatos D; Tsikaris V
Biopolymers; 2000-2001; 56(1):20-6. PubMed ID: 11582574
[TBL] [Abstract][Full Text] [Related]
5. Discovery and structure--activity relationship studies of a novel and specific peptide motif, Pro-X-X-X-Asp-X, as a platelet fibrinogen receptor antagonist.
Hayashi Y; Katada J; Sato Y; Igarashi K; Takiguchi Y; Harada T; Muramatsu M; Yasuda E; Uno I
Bioorg Med Chem; 1998 Mar; 6(3):355-64. PubMed ID: 9568289
[TBL] [Abstract][Full Text] [Related]
6. [Effect of RGD-containing peptides on platelet aggregation].
Vasil'eva TM; Makarov VA; Petrukhina GN; Voiushina TL; Iusupova MP; Novgorodova SA; Kotlova EK
Eksp Klin Farmakol; 2006; 69(4):39-42. PubMed ID: 16995437
[TBL] [Abstract][Full Text] [Related]
7. Synthetic RGD peptides derived from the adhesive domains of snake-venom proteins: evaluation as inhibitors of platelet aggregation.
Lu X; Deadman JJ; Williams JA; Kakkar VV; Rahman S
Biochem J; 1993 Nov; 296 ( Pt 1)(Pt 1):21-4. PubMed ID: 8250845
[TBL] [Abstract][Full Text] [Related]
8. Synthesis of cyclic oligopeptides containing an Arg-Gly-Asp (RGD) sequence.
Sofuku S; Hoshida A; Shimada T; Takada Y; Takakuwa T
Chem Pharm Bull (Tokyo); 1999 Dec; 47(12):1799-801. PubMed ID: 10748723
[TBL] [Abstract][Full Text] [Related]
9. Circular dichroism studies of type III collagen mimetic peptides with anti- or pro-aggregant activities on human platelets.
Pêcher J; Pires V; Djaafri I; Da Nascimento S; Fauvel-Lafève F; Legrand C; Sonnet P
Eur J Med Chem; 2009 Jun; 44(6):2643-50. PubMed ID: 19056149
[TBL] [Abstract][Full Text] [Related]
10. Novel Cu(II)-RGD-octapeptides: Synthesis, coordination mode, in vitro anti-platelet aggregation/in vivo anti-thrombotic evaluation and correlation of sequence with nano-structure.
Li N; Kang G; Gui L; Zhao M; Wang W; Zhang J; Yue YF; Peng S
Nanomedicine; 2011 Aug; 7(4):403-9. PubMed ID: 21272663
[TBL] [Abstract][Full Text] [Related]
11. Novel fibrinogen receptor antagonists. RGDF mimetics, derivatives of 4-(isoindoline-5-yl)amino-4-oxobutyric acid.
Krysko AA; Chugunov BM; Malovichko OL; Andronati SA; Kabanova TA; Karaseva TL; Kiriyak AV
Bioorg Med Chem Lett; 2004 Nov; 14(22):5533-5. PubMed ID: 15482918
[TBL] [Abstract][Full Text] [Related]
12. Three-dimensional quantitative structure-activity relationship analyses of RGD mimetics as fibrinogen receptor antagonists.
Miyashita M; Akamatsu M; Hayashi Y; Ueno T
Bioorg Med Chem Lett; 2000 May; 10(9):859-63. PubMed ID: 10853647
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis of novel tryptophan derivatives for antiplatelet aggregation activity based on tripeptide pENW (pGlu-Asn-Trp).
Xie Z; Feng S; Wang Y; Cao C; Huang J; Chen Y; Kong Y; Li Z
Eur J Med Chem; 2015 Sep; 102():363-74. PubMed ID: 26298494
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and properties of peptidomimetics--inhibitors of platelet aggregation.
Andronati SA; Krysko AA; Kabanov VM; Karaseva TL; Kabanova TA
Acta Pol Pharm; 2000 Nov; 57 Suppl():15-21. PubMed ID: 11293251
[TBL] [Abstract][Full Text] [Related]
15. Development of a novel potent peptidyl platelet preserving agent: molecular design and biologic activity.
Ozeki E; Matsuda T
ASAIO Trans; 1990; 36(3):M562-4. PubMed ID: 2252751
[TBL] [Abstract][Full Text] [Related]
16. Design and synthesis of novel cyclic RGD-containing peptides as highly potent and selective integrin alpha IIb beta 3 antagonists.
Cheng S; Craig WS; Mullen D; Tschopp JF; Dixon D; Pierschbacher MD
J Med Chem; 1994 Jan; 37(1):1-8. PubMed ID: 7507165
[TBL] [Abstract][Full Text] [Related]
17. A novel surface-active peptide derivative exhibits in vitro inhibition of platelet aggregation.
Ramesh CV; Jayakumar R; Puvanakrishnan R
Peptides; 1998; 19(10):1695-702. PubMed ID: 9880074
[TBL] [Abstract][Full Text] [Related]
18. Pyrazole derivatives as inhibitors of arachidonic acid-induced platelet aggregation.
Levent S; Çalışkan B; Çiftçi M; Özkan Y; Yenicesu I; Ünver H; Banoglu E
Eur J Med Chem; 2013 Jun; 64():42-53. PubMed ID: 23639653
[TBL] [Abstract][Full Text] [Related]
19. Development of a small RGD peptide fibrinogen receptor antagonist with potent antiaggregatory activity in vitro.
Samanen J; Ali F; Romoff T; Calvo R; Sorenson E; Vasko J; Storer B; Berry D; Bennett D; Strohsacker M
J Med Chem; 1991 Oct; 34(10):3114-25. PubMed ID: 1920361
[TBL] [Abstract][Full Text] [Related]
20. [Antiaggregation activity of arachidonic acid conjugates with neurotropic peptides proglyprol and semax].
Bezuglov VV; Gretskaia NM; Vasil'eva TM; Petrukhina GN; Andreeva LA; Miasoedov NF; Makarov VA
Eksp Klin Farmakol; 2014; 77(6):30-2. PubMed ID: 25102733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
